Heparan sulfate signaling in cancer

Journal Article (Review)

Heparan sulfate (HS) is a biopolymer consisting of variably sulfated repeating disaccharide units. The anticoagulant heparin is a highly sulfated intracellular variant of HS. HS has demonstrated roles in embryonic development, homeostasis, and human disease via non-covalent interactions with numerous cellular proteins, including growth factors and their receptors. HS can function as a co-receptor by enhancing receptor-complex formation. In other contexts, HS disrupts signaling complexes or serves as a ligand sink. The effects of HS on growth factor signaling are tightly regulated by the actions of sulfyltransferases, sulfatases, and heparanases. HS has important emerging roles in oncogenesis, and heparin derivatives represent potential therapeutic strategies for human cancers. Here we review recent insights into HS signaling in tumor proliferation, angiogenesis, metastasis, and differentiation. A cancer-specific understanding of HS signaling could uncover potential therapeutic targets in this highly actionable signaling network. © 2014 Elsevier Ltd.

Full Text

Duke Authors

Cited Authors

  • Knelson, EH; Nee, JC; Blobe, GC

Published Date

  • January 1, 2014

Published In

Volume / Issue

  • 39 / 6

Start / End Page

  • 277 - 288

Electronic International Standard Serial Number (EISSN)

  • 1362-4326

International Standard Serial Number (ISSN)

  • 0968-0004

Digital Object Identifier (DOI)

  • 10.1016/j.tibs.2014.03.001

Citation Source

  • Scopus